Zobrazeno 1 - 10
of 195
pro vyhledávání: '"David G Menter"'
Autor:
David G Menter, Victoria P Ramsauer, Sam Harirforoosh, Kanishka Chakraborty, Peiying Yang, Linda Hsi, Robert A Newman, Koyamangalath Krishnan
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e28813 (2011)
3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) inhibitors, commonly known as statins, may possess cancer preventive and therapeutic properties. Statins are effective suppressors of cholesterol synthesis with a well-established risk-benefit r
Externí odkaz:
https://doaj.org/article/32ec334c7acb403180dbabb4978977f7
Autor:
David G, Menter, Robert S, Bresalier
Publikováno v:
Annual Review of Pharmacology and Toxicology. 63:165-186
Chemoprevention refers to the use of natural or synthetic agents to reverse, suppress, or prevent the progression or recurrence of cancer. A large body of preclinical and clinical data suggest the ability of aspirin to prevent precursor lesions and c
Autor:
Alexey V. Sorokin, Preeti Kanikarla Marie, Lea Bitner, Muddassir Syed, Melanie Woods, Ganiraju Manyam, Lawrence N. Kwong, Benny Johnson, Van K. Morris, Philip Jones, David G. Menter, Michael S. Lee, Scott Kopetz
Publikováno v:
Cancer Research. 82:3335-3344
KRAS and NRAS mutations occur in 45% of colorectal cancers, with combined MAPK pathway and CDK4/6 inhibition identified as a potential therapeutic strategy. In the current study, this combinatorial treatment approach was evaluated in a co-clinical tr
Autor:
Anil Korkut, Chris Sander, Scott Kopetz, Timothy A. Yap, Patrick G. Pilié, David G. Menter, Augustin Luna, Jacob H. Elnaggar, Parisa Imanirad, Behnaz Bozorgui, Zeynep Dereli, Gonghong Yan, Elisabeth K. Dowling, Xubin Li
Cancer cells depend on multiple driver alterations whose oncogenic effects can be suppressed by drug combinations. Here, we provide a comprehensive resource of precision combination therapies tailored to oncogenic coalterations that are recurrent acr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6621292947776bd8e421d927dbfecf67
https://doi.org/10.1158/2159-8290.c.6549560
https://doi.org/10.1158/2159-8290.c.6549560
Autor:
Anil Korkut, Chris Sander, Scott Kopetz, Timothy A. Yap, Patrick G. Pilié, David G. Menter, Augustin Luna, Jacob H. Elnaggar, Parisa Imanirad, Behnaz Bozorgui, Zeynep Dereli, Gonghong Yan, Elisabeth K. Dowling, Xubin Li
Supplementary Table from Precision Combination Therapies Based on Recurrent Oncogenic Coalterations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03b0c3ddcfcc4c082091197c01886b3f
https://doi.org/10.1158/2159-8290.22541135
https://doi.org/10.1158/2159-8290.22541135
Autor:
Anil Korkut, Chris Sander, Scott Kopetz, Timothy A. Yap, Patrick G. Pilié, David G. Menter, Augustin Luna, Jacob H. Elnaggar, Parisa Imanirad, Behnaz Bozorgui, Zeynep Dereli, Gonghong Yan, Elisabeth K. Dowling, Xubin Li
Supplementary Data from Precision Combination Therapies Based on Recurrent Oncogenic Coalterations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56948a7772330ad1338aa3a92fca8c28
https://doi.org/10.1158/2159-8290.22541174.v1
https://doi.org/10.1158/2159-8290.22541174.v1
Supplementary Figure from Precision Combination Therapies Based on Recurrent Oncogenic Coalterations
Autor:
Anil Korkut, Chris Sander, Scott Kopetz, Timothy A. Yap, Patrick G. Pilié, David G. Menter, Augustin Luna, Jacob H. Elnaggar, Parisa Imanirad, Behnaz Bozorgui, Zeynep Dereli, Gonghong Yan, Elisabeth K. Dowling, Xubin Li
Supplementary Figure from Precision Combination Therapies Based on Recurrent Oncogenic Coalterations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::405a813b47ab9906d7cce9d6694e4550
https://doi.org/10.1158/2159-8290.22541171.v1
https://doi.org/10.1158/2159-8290.22541171.v1
Autor:
Scott Kopetz, Garth Powis, Michael J. Overman, Jeffrey Morris, Bradley M. Broom, Mingshan Cheng, Susan Airhart, Feng Tian, Christopher Bristow, Bahar Salimian Rizi, Alexey V. Sorokin, Ji Wu, Shanequa Manuel, Maria P. Morelli, Andreas Varkaris, David G. Menter, Zhi-Qin Jiang, Kanwal Raghav, Anastasia Katsiampoura
Hematoxylin and eosin staining showing conformity of grade between patient sample and respective established xenografts from both primary and metastatic sites.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a2bb06082f7ca75c4469315e54779cb
https://doi.org/10.1158/1535-7163.22503981
https://doi.org/10.1158/1535-7163.22503981
Autor:
Scott Kopetz, Garth Powis, Michael J. Overman, Jeffrey Morris, Bradley M. Broom, Mingshan Cheng, Susan Airhart, Feng Tian, Christopher Bristow, Bahar Salimian Rizi, Alexey V. Sorokin, Ji Wu, Shanequa Manuel, Maria P. Morelli, Andreas Varkaris, David G. Menter, Zhi-Qin Jiang, Kanwal Raghav, Anastasia Katsiampoura
Association between surgical specimen size and rate of PDX establishment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a1a3561b3894370a65e992a0deea967
https://doi.org/10.1158/1535-7163.22503978.v1
https://doi.org/10.1158/1535-7163.22503978.v1
Autor:
Shrikanth A.G. Reddy, James L. Abbruzzese, David G. Menter, Kanaga Sabapathy, Murray Korc, Francois-Xavier Claret, Ronghua Zhang, Yixin Yao, Takayuki Asano, Sonyo Shin
Supplementary Figure. 1A. Nuclear extracts (N.E.) from various serum-starved pancreatic cancer cell lines were probed for NF-κBbinding activity. Also included were serum-starved Panc-28 cells after stimulation by IL-1. Supershift assays were perform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07670070668bd8cc0027a2787ef1511f
https://doi.org/10.1158/1541-7786.22518562.v1
https://doi.org/10.1158/1541-7786.22518562.v1